Research output per year
Research output per year
- 25 results
Search results
-
2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
Ten Ham, R. M. T., Rohaan, M. W., Jedema, I., Kessels, R., Stegeman, W., Scheepmaker, W., Nuijen, B., Nijenhuis, C., Lindenberg, M., Borch, T. H., Monberg, T., Donia, M., Marie Svane, I., van Harten, W., Haanen, J. & Retel, V. P., 26 Mar 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, p. 1-24 24 p., e008372.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies
Cuende, N., Tullius, S. G., Izeta, A., Plattner, V., Börgel, M., Ciccocioppo, R., Correa-Rocha, R., Koh, M. B. C., De Angelis, V., Gondolesi, G. E., Ten Ham, R., Porte, R. J., Hernández-Maraver, D., Hawthorne, W. J., Sureda, A., Orlando, G., Haraldsson, B., Ascher, N. L., Dominguez-Gil, B. & Oniscu, G. C., Jan 2025, In: Transplantation. 109, 1, p. 36-47Research output: Contribution to journal › Review article › peer-review
-
2023
Geneesmiddelen voor Geavanceerde Therapie (ATMP’s) in Nederland: Veldverkenning, Knelpuntanalyse en Activiteitenkaart
Gort, J., van Hattem, C., Bloem, L. T. & ten Ham, R., 2023Research output: Book/Report › Report › Academic
Open Access -
Gene therapies, uncertainty, and decision-making: thinking about the last mile at the first step
Frederix, G. & ten Ham, R., Aug 2023, In: Expert Review of Pharmacoeconomics and Outcomes Research. 23, 8, p. 853-856 4 p., doi.org/10.1080/14737167.2023.2245138.Research output: Contribution to journal › Editorial › Academic › peer-review
-
Short- and longer-term goals for change – A report from the 2nd workshops of the EHC Think Tank Workstreams on Access Equity and Future Care Pathways
Gacser, Z., SKOUW-RASMUSSEN, N., Bourke, S., ten Ham, R., Hosszu, D. & Thinktank, E., Jan 2023, In: The Journal of Haemophilia Practice. 10, 1, p. 155-163 doi.org/10.2478/jhp-2023-0023.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Toward Transplantation of Liver Organoids: From Biology and Ethics to Cost-effective Therapy
Ten Dam, M. J. M., Frederix, G. W. J., Ten Ham, R. M. T., Van Der Laan, L. J. W. & Schneeberger, K., 1 Aug 2023, In: Transplantation. 107, 8, p. 1706-1717 12 p., 10.1097/TP.0000000000004520.Research output: Contribution to journal › Review article › peer-review
Open AccessFile1 Downloads (Pure) -
2022
Gen- en celtherapieën: de hobbelige route van lab naar de patiënt
ten Ham, R. & de Haar, C., 21 Jan 2022, In: Pharmaceutisch Weekblad. 3, p. 8-12 5 p.Research output: Contribution to journal › Article › Professional
-
Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England
ten Ham, R. M. T., Frederix, G. W. J., Wu, O., Goettsch, W., Leufkens, H. G. M., Klungel, O. H. & Hoekman, J., Mar 2022, In: Value in Health. 25, 3, p. 390-399 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)3 Downloads (Pure) -
Kostprijs-plusmodel geeft inzicht in reële prijzen gentherapieën
Thielen, F. W. F., Heine, R. J., van den Berg, S., ten Ham, R. & Uyl-de Groot, C. A., 25 Nov 2022, In: Pharmaceutisch Weekblad. 47, p. 18-20 3 p.Research output: Contribution to journal › Article › Professional
-
Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
Ten Ham, R. M. T., Walker, S. M., Soares, M. O., Frederix, G. W. J., Leebeek, F. W. G., Fischer, K., Coppens, M. & Palmer, S. J., 28 Feb 2022, In: HemaSphere. 6, 2, p. 1-11 e679.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma
Thielen, F. W. F., Heine, R. J., van den Berg, S., ten Ham, R. & Uyl-de Groot, C. A., Dec 2022, In: Cytotherapy. 24, 12, p. 1245-1258 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Rohaan, M. W., Borch, T. H., van den Berg, J. H., Met, Ö., Kessels, R., Geukes Foppen, M. H., Stoltenborg Granhøj, J., Nuijen, B., Nijenhuis, C., Jedema, I., van Zon, M., Scheij, S., Beijnen, J. H., Hansen, M., Voermans, C., Noringriis, I. M., Monberg, T. J., Holmstroem, R. B., Wever, L. D. V. & van Dijk, M. & 37 others, , 8 Dec 2022, In: The New England journal of medicine. 387, 23, p. 2113-2125 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
2021
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients
ten Ham, R. M. T., van Nuland, M., Vreman, R. A., de Graaf, L. G., Rosing, H., Bergman, A. M., Huitema, A. D. R., Beijnen, J. H. & Hövels, A. M., Jan 2021, In: Value in Health. 24, 1, p. 121-128 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Development, Market Authorization and Market Access of cell and gene therapies
ten Ham, R., 4 Jun 2021, Utrecht University. 274 p.Research output: Thesis › Doctoral thesis 3 (Research UU / Graduation NOT UU)
Open Access -
Estimation of manufacturing development costs of cell-based therapies: a feasibility study
ten Ham, R. M. T., Nievaart, J. C., Hoekman, J., Cooper, R. S., Frederix, G. W. J., Leufkens, H. G. M., Klungel, O. H., Ovelgönne, H., Hoefnagel, M. H. N., Turner, M. L. & Mountford, J. C., Aug 2021, In: Cytotherapy. 23, 8, p. 730-739 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)1 Downloads (Pure) -
The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer
Jeong, C. W., Herlemann, A., Cowan, J. E., Broering, J. M., ten Ham, R. M. T., Wilson, L. S., Carroll, P. R. & Cooperberg, M. R., 2021Research output: Other contribution › Academic
Open Access -
2020
A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
ten Ham, R., Klungel, O., Leufkens, H. G. M. & Frederix, G., Sept 2020, In: Value in Health. 23, 9, p. 1268-1280 13 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile11 Downloads (Pure) -
Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection
ten Ham, R., Hovels, A., Klungel, O., Broekmans, A. & Hoekman, J., Feb 2020, In: Trends in Pharmacological Sciences. 41, 2, p. 67-71 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings
Ham, R., Hovels, A. M., Hoekman, J., Frederix, G., Leufkens, H. G. M., Klungel, O., Jedema, I., Nikolic, T., van Pel, M., Zwaginga, J. J., de Goede, A., Schreibelt, G., de Vries, I. J. M., Dolstra, H., Ovelgonne, H., Meij, P., Mountford, J. C., Turner, M. L. & Hoefnagel, M., Jul 2020, In: Cytotherapy. 22, 7, p. 388-397 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Downloads (Pure) -
2019
REVIEW OF ECONOMIC EVALUATIONS FOR GENE THERAPIES:ARE WE READY FOR THE FUTURE?
ten Ham, R., Leufkens, H. G., Klungel, O. & Fredrix, G., 2019, In: Value in Health. 1 p., PBI75.Research output: Contribution to journal › Meeting Abstract › Academic
-
2018
A NEW GRAPHICAL REPRESENTATION OF PROBABILITY SENSITIVITY ANALYSIS RESULTS AS AN ALTERNATIVE FOR THE SCATTER-PLOT
Geenen, J. W., Vreman, R. A., ten Ham, R., Boersma, C., Klungel, O. & Hovels, A. M., 2018, In: Value in Health. 21, 1 p., PRM145 .Research output: Contribution to journal › Meeting Abstract › Academic
-
CHALLENGES IN ACHIEVING MARKET ACCESS SUCCESS FOR ADVANCED THERAPIES IN EUROPE: A CASE STUDY
ten Ham, R., Hovels, A. M., Hoekman, J., Broekmans, A., Leufkens, H. G. & Klungel, O., 2018, In: Value in Health. 21, 1 p., PHP369.Research output: Contribution to journal › Meeting Abstract › Academic
-
COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
Vreman, R. A., van Nuland, M., ten Ham, R., de Vries Schultink, A., Rosing, H., Schellens, J. H., Beijnen, J. H. & Hovels, A. M., 2018, In: Value in Health. 21, 1 p., PCN191.Research output: Contribution to journal › Meeting Abstract › Academic
-
2014
Mapping HRQoL questionnaires into utilities for prostate cancer patients: Epic, UCLA-PCI, SHIM, IPSS, SF36 to PORPUS.
ten Ham, R., Broering, J. M., Cooperberg, M. R., Kornak, J., Wilson, L. S. & Carroll, P. R., 20 May 2014, In: Journal of Clinical Oncology. 32, 15 suppl.Research output: Contribution to journal › Meeting Abstract › Academic
-
Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test
ten Ham, R., Wilson, L. S., Broering, J. M., Cooperberg, M. R. & Carroll, P., 2014, In: Value in Health. 17, 1 p., PCN207.Research output: Contribution to journal › Meeting Abstract › Academic